英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Norethindrone Impurity 7 |
|
|
詳細(xì)
|
Norethindrone Related Compound |
17-ethynyl-4-estrene-3,17-diol-3-acetate-17-(3'-acetoxy-2'-butenoate) |
142154-46-9 |
詳細(xì)
|
6-Keto Norethindrone Acetate (Norethindrone Impurity G) |
6-酮基醋酸炔諾酮 |
438244-27-0 |
詳細(xì)
|
6-beta-Hydroxy Norethindrone Acetate (Norethindrone Acetate Impurity F) |
6-Β羥基醋酸炔諾酮 |
6856-27-5 |
詳細(xì)
|
Rivaroxaban Impurity 15 |
利伐沙班乙酰草酰胺雜質(zhì) |
931204-39-6 |
詳細(xì)
|
Rivaroxaban Metabolite 8 |
利伐沙班代謝物8 |
|
詳細(xì)
|
6,10-di-Hydroxy Norethindrone Acetate |
6,10-二羥基醋酸炔諾酮 |
|
詳細(xì)
|
Rivaroxaban Impurity 3 |
利伐沙班雜質(zhì)3 |
|
詳細(xì)
|
Olopatadine Carbaldehyde HCl |
|
|
詳細(xì)
|
Norethindrone Impurity O |
|
|
詳細(xì)
|
6,7-Didehydro Norethindrone |
6, 7-二脫氫炔諾酮 |
31528-46-8 |
詳細(xì)
|
6-alpha-Hydroxy Norethindrone Acetate |
6-Α羥基醋酸炔諾酮 |
6856-28-6 |
詳細(xì)
|
(S,S,R,R)-Orlistat |
(S,S,R,R)-奧利司他 |
111466-62-7 |
詳細(xì)
|
Olopatadine Acetaldehyde |
奧洛他定醛基雜質(zhì) |
1376615-97-2 |
詳細(xì)
|
6-Beta-Hydroxy-19-Norandrostenedione |
炔諾酮雜質(zhì)23(6-Β-羥基-19-去甲雄烯二酮) |
5949-49-5 |
詳細(xì)
|
Rivaroxaban Impurity 5 |
利伐沙班雜質(zhì)5 |
|
詳細(xì)
|
Rivaroxaban Impurity 4 |
利伐沙班雜質(zhì)H |
1429334-00-8 |
詳細(xì)
|
Ophthazin Impurity 2 |
雙肼酞嗪雜質(zhì)2 |
1044569-46-1 |
詳細(xì)
|
Rivaroxaban Impurity 12 |
利伐沙班雜質(zhì) 12 |
936232-22-3 |
詳細(xì)
|
Rivaroxaban Impurity 25 |
利伐沙班雜質(zhì)25 |
|
詳細(xì)
|
Ophthazin Sulfate |
硫酸雙肼屈嗪 |
7327-87-9 |
詳細(xì)
|
Orlistat Impurity M1 |
奧利司他雜質(zhì)M1 |
130676-66-3 |
詳細(xì)
|
(S,R,R,R)-Orlistat |
(S,R,R,R) -奧利司他 |
111466-61-6 |
詳細(xì)
|
Delta-5(6)-Norethindrone (Norethindrone Impurity C) |
Δ-5(6)-NORETHINDRONE |
22933-71-7 |
詳細(xì)
|
Orlistat Impurity 2 |
奧利司他雜質(zhì)2 |
130676-63-0 |
詳細(xì)
|
Rivaroxaban Related Compound (Ethyl 4-(3-Oxomorpholino)-Phenylcarbamate) |
利伐沙班中間體2 |
1327778-39-1 |
詳細(xì)
|
Rivaroxaban Impurity 16 |
利伐沙班雜質(zhì) 16 |
|
詳細(xì)
|
Rivaroxaban Impurity 21 |
利伐沙班雜質(zhì) 21 |
1328136-38-4 |
詳細(xì)
|
Rivaroxaban Impurity 26 |
Rivaroxaban Impurity 26 |
1838133-00-8 |
詳細(xì)
|
Norgestrel |
炔諾孕酮 |
6533-00-2 |
詳細(xì)
|
Norethisterone Impurity A |
|
|
詳細(xì)
|
Rivaroxaban Related Compound |
2-氯噻吩-5-甲酸 |
24065-33-6 |
詳細(xì)
|
N-Deformyl-N-pivaloyl Orlistat |
N-DEFORMYL-N-PIVALOYL ORLISTAT |
1356017-35-0 |
詳細(xì)
|
Rivaroxaban Metabolite 9 |
利伐沙班代謝物9 |
|
詳細(xì)
|
Rivaroxaban Dimer Impurity |
|
|
詳細(xì)
|
Rivaroxaban Impurity 23 |
利伐沙班雜質(zhì)23 |
|
詳細(xì)
|
Orlistat degradation product sodium salt |
|
|
詳細(xì)
|
Norgestrel Sulfate Sodium Salt |
諾格瑞硫酸鹽 |
|
詳細(xì)
|
3-Methyl-2-quinoxalinecarboxylic acid |
3-甲基-喹啉-2-甲酸 |
74003-63-7 |
詳細(xì)
|
Norethindrone EP Impurity F |
炔諾酮雜質(zhì)6 |
96487-85-3 |
詳細(xì)
|
Octyl Orlistat |
奧利司他雜質(zhì)8(奧利司他辛基) |
1243011-56-4 |
詳細(xì)
|
(R,S,S,S)-Orlistat |
(R,S,S,S)-奧利司他 |
104872-28-8 |
詳細(xì)
|
17,17-bis(17-hydroxy-18a-homoestr-4-ene-3-one |
17,17-雙(17-羥基-18A-HOMOESTR-4-ENE-3-ONE |
|
詳細(xì)
|
Rivaroxaban Impurity 1 |
利伐沙班雜質(zhì)1 |
|
詳細(xì)
|
Rivaroxaban Impurity 6 |
利伐沙班雜質(zhì)6 |
|
詳細(xì)
|
Rivaroxaban Impurity 14 |
利伐沙班相關(guān)化合物D |
1365267-35-1 |
詳細(xì)
|
Nuzhenide Impurity 1 |
女貞子甙雜質(zhì)1 |
|
詳細(xì)
|
Rivaroxaban Impurity 13 |
利伐沙班代謝物M1 |
1160169-98-1 |
詳細(xì)
|
Rivaroxaban Impurity 29 |
Rivaroxaban Impurity 29 |
|
詳細(xì)
|
Orlistat Related Compound ((2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid) |
奧利司他開(kāi)環(huán)雜質(zhì)(2S,3R,5S)異構(gòu)體 |
130793-28-1 |
詳細(xì)
|
Orlistat USP Related Compound E |
N-甲?;?L-異亮氨酸 (1S)-1-[[(2S,3S)-3-己基-4-氧代-2-氧雜環(huán)丁基]甲基]十二烷基酯 |
1072902-75-0 |
詳細(xì)
|
Alpha-hydroxy Olopatadine Sodium Salt ( Olopatadine Impurity A) |
阿爾法羥基奧洛他定鈉鹽(奧洛他定雜質(zhì)) |
|
詳細(xì)
|
6-beta-Hydroxy Norethindrone (Norethindrone Impurity H) |
6-Β羥基炔諾酮 |
51724-44-8 |
詳細(xì)
|
Rivaroxaban Impurity 19 |
利伐沙班雜質(zhì) 19 |
|
詳細(xì)
|
Rivaroxaban Impurity 27 |
利伐沙班雜質(zhì)27 |
1369969-44-7 |
詳細(xì)
|
N-Didesmethyl Olopatadine HCl |
N-DidesMethyl Olopatadine HCl |
113835-94-2 |
詳細(xì)
|
Rivaroxaban Impurity L |
利伐沙班雜質(zhì)L |
|
詳細(xì)
|
Olaparib Impurity 1 |
|
|
詳細(xì)
|
Rivaroxaban Impurity 24 |
利伐沙班雜質(zhì)24 |
|
詳細(xì)
|
Orlistat Related Compound [(S)-3-Hexyl-5,6-dihydro-6-undecyl-2H-pyran-2-one |
奧利司他二氫吡喃酮雜質(zhì) |
130676-64-1 |
詳細(xì)
|
6,7-Dehydro Norethindrone Acetate |
17-羥基-19-去甲-17ALPHA-孕甾-4,6-二烯-20-炔-3-酮乙酸酯 |
106765-04-2 |
詳細(xì)
|
N-Deformyl-N-benzyloxycarbonyl Orlistat |
N-DEFORMYL-N-BENZYLOXYCARBONYL ORLISTAT |
108051-94-1 |
詳細(xì)
|
5-Methyl-L-Norleucine Orlistat Analogue |
奧利司類似物 |
1356847-30-7 |
詳細(xì)
|
trans-10-Hydroxy Nortriptyline |
-E-10-羥基去甲替林 |
74853-74-0 |
詳細(xì)
|
Delta 5(10)-Norethindrone Acetate |
Δ5(10)醋酸炔諾酮 |
19637-28-6 |
詳細(xì)
|
Delta-5(6)-Norethindrone Acetate (Impurity C) |
醋酸炔諾酮雜質(zhì)C |
1175129-26-6 |
詳細(xì)
|
Norethindrone Impurity E |
炔諾酮雜質(zhì)E |
66964-58-7 |
詳細(xì)
|
Rivaroxaban Metabolite 5 |
利伐沙班代謝物5 |
|
詳細(xì)
|
Nortriptyline Impurity G |
去甲替林N-氨基甲酸乙酯 |
16234-88-1 |
詳細(xì)
|
3alfa,5-beta-Tetrahydro Levonorgestrel |
3Α,5-Β-甲氫左炔諾孕酮 |
|
詳細(xì)
|
Rivaroxaban Impurity 2 |
利伐沙班雜質(zhì)2 |
|
詳細(xì)
|
Rivaroxaban Impurity 7 |
利伐沙班雜質(zhì)7 |
|
詳細(xì)
|
Rivaroxaban Impurity G |
利伐沙班雜質(zhì)G |
721401-53-2 |
詳細(xì)
|
Rivaroxaban Related Compound (5-Chloro-2-Thiophenecarboxylic Acid N-Methylamide) |
5-氯噻吩-2-甲酰甲胺 |
97799-98-9 |
詳細(xì)
|
Orlistat Impurity 3 |
奧利司他雜質(zhì)3 |
|
詳細(xì)
|
Olopatadine N-Oxide |
奧洛他定N氧化物 |
203188-31-2 |
詳細(xì)
|
Orlistat Dimer Impurity |
奧利司他二聚物雜質(zhì) |
881900-54-5 |
詳細(xì)
|
Norethindrone Impurity 2 |
炔諾酮雜質(zhì)E |
79727-03-0 |
詳細(xì)
|
Orlistat Related Compound D |
奧利司他相關(guān)化合物D |
130793-27-0 |
詳細(xì)
|
Nortriptyline N-Glucuronide |
去甲替林 N-葡糖苷酸 |
|
詳細(xì)
|
N-Desmethyl Olopatadine HCl |
N-去甲鹽酸奧洛他定 |
|
詳細(xì)
|
Ophthazin Impurity 1 |
雙肼酞嗪雜質(zhì)1 |
|
詳細(xì)
|
Rivaroxaban Impurity 10 |
|
|
詳細(xì)
|
Rivaroxaban Impurity 11 |
利伐沙班雜質(zhì) 11 |
1411775-06-8 |
詳細(xì)
|
Rivaroxaban O-Carboxy Benzamide Impurity |
利伐沙班雜質(zhì) 34 |
|
詳細(xì)
|
Rivaroxaban Impurity 28 |
利伐沙班雜質(zhì)28 |
2489689-18-9 |
詳細(xì)
|
Rivaroxaban Impurity 20 |
N-甲基鄰苯二甲酰亞胺 |
550-44-7 |
詳細(xì)
|
Rivaroxaban Impurity 22 |
利伐沙班雜質(zhì)22 |
|
詳細(xì)
|
Rivaroxaban Impurity 9 |
利伐沙班鄰苯二甲酰亞胺雜質(zhì) |
446292-08-6 |
詳細(xì)
|
(S,R,S,S) Orlistat |
(S,R,S,S) -奧利司他 |
111466-63-8 |
詳細(xì)
|
Rivaroxaban Impurity 8 |
N,N'-二[{(5S)-2-氧代-3-[4-(3-氧代-4-嗎啉基)苯基]-1,3-惡唑啉-5-基}甲基]苯基-1,2-二酰胺 |
1365267-36-2 |
詳細(xì)
|
Olaparib Impurity 2 |
奧拉帕利雜質(zhì)2 |
|
詳細(xì)
|
Nortriptyline Impurity H |
去甲替林雜質(zhì)H |
24755-73-5 |
詳細(xì)
|
6β,17-Norethindrone Diacetate |
|
|
詳細(xì)
|
Rivaroxaban Related Compound (R-4-(4-(5-(Aminomethyl)-2-Oxooxazolidin-3-yl)phenyl-Morpholin-3-One HCl) |
利伐沙班相關(guān)化合物 |
1429311-47-6 |
詳細(xì)
|
Norethindrone Acetate Dimer |
|
|
詳細(xì)
|
Carboxylate Ion of Nystatin |
|
|
詳細(xì)
|
Octaverine Hydrochloride |
辛凡林 |
6775-26-4 |
詳細(xì)
|
Norethindrone 3-isopropyldienol Ether |
|
|
詳細(xì)
|
Norethindrone Acetate 3-Isopropylenol Ether |
Norethindrone Acetate 3-Isopropylenol Ether |
|
詳細(xì)
|